Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study

Cutland C. L., Nolan T., Halperin S. A., Kurugol Z. A., Ahmed K., Perrett K. P., ...More

VACCINE, vol.36, no.14, pp.1908-1916, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 14
  • Publication Date: 2018
  • Doi Number: 10.1016/j.vaccine.2018.02.013
  • Journal Name: VACCINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1908-1916
  • Hacettepe University Affiliated: Yes


Background: We evaluated the immunogenicity and safety of 1 and 2 doses of quadrivalent meningococcal serogroup A, C, W and Y tetanus toxoid-conjugate vaccine (MenACWY-IT) given alone or co administered with 13-valent pneumococcal conjugate vaccine (PCV13) in toddlers.